Home › NDC Lookup › RxCUI directory › RxCUI 885205

2 ML benztropine mesylate 1 MG/ML Injection — RxCUI 885205

Name: 2 ML benztropine mesylate 1 MG/ML Injection (RxCUI 885205)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 885205 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI885205

Official name2 ML benztropine mesylate 1 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbenztropine mesylate 2 MG per 2 ML Injection; benztropine mesylate 2 MG in 2 ML Injection

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)670 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Benztropine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Benztropine helps reduce the stiffness, tremors, and movement problems that come with parkinsonism. It works by blocking certain chemical signals in the brain that are out of balan...
What exactly is benztropine supposed to do for me?
This medication has a long-lasting effect, so many people do best taking their full dose at bedtime — it can help you move more comfortably during the night and make it easier to g...
Should I take my tablet in the morning or at night?

📖 Read our full Benztropine guide →

🕸️ Concept Web — How 2 ML benztropine mesylate 1 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML benztropine mesylate 1 MG/ML Injection RxCUI 885205 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Benztropine 1424 IN
- Benztropine mesylate 18927 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Benztropine Injection 1726504 SCDF
- Benztropine mesylate Injection 2647650 SCDFP
- Benztropine Injectable Product 1152994 SCDG
- Benztropine mesylate Injectable Product 2662131 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Benztropine mesylate 1 MG/ML 885204 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Benztropine mesylate 1 MG/ML SCDC · 885204
Benztropine Injection SCDF · 1726504
Benztropine mesylate Injection SCDFP · 2647650
Benztropine Injectable Product SCDG · 1152994
Benztropine mesylate Injectable Product SCDGP · 2662131

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 885205 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9233-05	5 VIAL in 1 BOX (0143-9233-05) / 2 mL in 1 VIAL (0143-9233-...	Benztropine Mesylate	Hikma Pharmaceuticals USA Inc.	2021-10-14
00143-9729-05	5 AMPULE in 1 CARTON (0143-9729-05) / 2 mL in 1 AMPULE (014...	Benztropine Mesylate	Hikma Pharmaceuticals USA Inc.	2009-09-01
63323-0970-02	5 VIAL in 1 BOX (63323-970-02) / 2 mL in 1 VIAL	BENZTROPINE MESYLATE	Fresenius Kabi USA, LLC	2011-05-31
68382-0860-10	5 VIAL in 1 CARTON (68382-860-10) / 2 mL in 1 VIAL (68382-8...	Benztropine Mesylate	Zydus Pharmaceuticals USA Inc.	2020-12-30
68475-0512-02	5 VIAL in 1 CARTON (68475-512-02) / 2 mL in 1 VIAL (68475-5...	Benztropine Mesylate	Navinta LLC	2020-11-24

Observed labelers: Hikma Pharmaceuticals USA Inc. (2) · Fresenius Kabi USA, LLC (1) · Navinta LLC (1) · Zydus Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0515	Inj benztropine mesylate	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.